bis-PEG2-endo-BCN
Code | Size | Price |
---|
TAR-T14631-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14631-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Bis-PEG2-endo-BCN is a two-unit cleavable polyethylene glycol (PEG) linker employed in the synthesis of antibody-drug conjugates (ADCs)[1].
CAS:
1476737-97-9
Formula:
C28H40N2O6
Molecular Weight:
500.636
Purity:
0.98
SMILES:
[H][C@@]12CCC#CCC[C@]1([H])[C@@H]2COC(=O)NCCOCCOCCNC(=O)OC[C@@H]1[C@]2([H])CCC#CCC[C@]12[H]
References
Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.